plg0206
Peptideexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jan 31, 2022 (NCT05137314)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07214311 | Phase 2/Phase 3 (Phase 3) | Dec 31, 2025 | Peptilogics |
| NCT05137314 | Phase 1 | Jan 31, 2022 | Department of Health and Human Services, Peptilogics, Wellcome Trust |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Peptilogics | For profit | 2 | 2 | 2 | 2022 |
| Department of Health and Human Services | Government | 1 | 0 | 1 | 2022 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1